![](https://www.business-standard.com/assets/web-assets/images/Business_Standard_685x385.jpg)
Suven Pharma soars after signing deal to acquire oligo drugs maker Sapala Organics
Suven Pharmaceuticals jumped 4.59% to Rs 697.85 after the company the signing of definitive agreements for acquiring 100% of equity shares of Sapala Organics. Sapala Organics is a Hyderabad-based CDMO focused on oligo drugs and nucleic acid building blocks …